Table 5.
Guideline reference
| #Number | Reference to GL | PrO GL followed | PO GL followed |
|---|---|---|---|
| #1[10] | Yes [28] | N | N |
| #2[11] | Yes [6] | Yes | Yes |
| #3[12] | No | / | / |
| #4[13] | Yes [6, 28] | N | Yes |
| #5[14] | Yes [6, 28] | Yes | Yes |
| #6[15] | Yes [6, 28] | Yes | Yes |
| #7[16] | No | / | / |
| #8[17] | Yes [6, 29] | Yes | Yes |
| #9[18] | No | No | No |
| #10[19] | No | / | / |
| #11[20] | Yes [6] | Yes | N |
| #12[21] | No | / | / |
| #13 [22] | No | / | / |
| #14[23] | No | / | / |
| #15[24] | No | / | / |
| #16[25] | No | / | / |
| #17[26] | No | / | / |
| #18[27] | Yes [28] | No | / |
PrO: pre-operative; PO: post-operative; N: not clearly stated; /: not in antiplatelet or anticoagulant therapy